58 Pharmaceutical Research companies

Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent i…

AstraZeneca is a global biopharmaceutical company that researches, develops, and commercializes prescription medicines in oncology, respiratory, and rare diseas…

We are long-term investors in engineering biology to treat - or better, cure - human disease.

We're biomedical researchers investing in a new generation of translational founders.

A venture capital firm uniquely dedicated to the frontier of neuroscience.

Novartis is a Basel-headquartered global pharmaceutical company developing innovative medicines, employing approximately 109,000 people and reaching over 280 mi…

Identifying true innovations and building ambitious companies.

We unite research, venture building, programs, and investments to make healthcare more affordable, accessible, and impactful.

A venture fund investing in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies globally.

We are a venture studio leveraging Alloy’s pre-competitive drug discovery platforms. Established drug discovery, scientific, and lab resources allow entrepreneu…

Equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.

Atlas Venture invests in early-stage life sciences innovation. We partner with remarkable entrepreneurs to build breakthrough biotech companies.

Accelerating life-extending therapies, treatments and cures for all myeloma patients.

Finchley Healthcare Ventures (FHCV) is a Canadian venture capital fund founded in 2022 specializing in investments within the rapidly evolving landscape of life…

Early-stage funding for European life sciences companies.

Investing in the future of medicine.

At Third Rock, we push the boundaries of science and technology to make a difference in the lives of patients and their families.

We identify, invest and nurture biotech companies that make a difference in healthcare.

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.

Aditum Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines.